Tobias Kohl

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

Susanne Schnittger, Tobias Kohl, Torsten Haferlach et al. · Blood · 2005 · 378 citations · Full text

The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice

Christina Schessl, Vijay P.S. Rawat, Monica Cusan et al. · Journal of Clinical Investigation · 2005 · 240 citations · Full text

Hematological Malignancy, Systems Biology, Signal Transduction +13

A protease assay for two-photon crosscorrelation and FRET analysis based solely on fluorescent proteins

Tobias Kohl, Katrin G. Heinze, Rene Kuhlemann et al. · Proceedings of the National Academy of Sciences · 2002 · 134 citations · Full text

BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts

Tobias Kohl, Christine Hellinger, Farid Ahmed et al. · Leukemia · 2007 · 107 citations

Primary Aml Blasts, Hematological Malignancy, Mixed-phenotype Acute Leukemia +8

KIT exon 8 mutations associated with core-binding factor (CBF)–acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor

Tobias Kohl, Susanne Schnittger, Joachim W. Ellwart et al. · Blood · 2004 · 96 citations · Full text